Mycophenolic acid news

All news on Mycophenolic acid: plants, production capacities, investments and involved companies.

3 June 2026

Johnson & Johnson: nipocalimab lowers SLE disease activity in Phase 2 JASMINE study

Phase 2 data show FcRn blocker nipocalimab reduced SLE activity versus placebo, with larger benefit in autoantibody‑positive patients and no new safety signals.

Who will be producing Mycophenolic acid in the future?

Find out with chemXplore Alpha

Learn more